« Previous
Next »
Journal of Hepatology
Volume 47, Issue 4
, Pages 444-446
, October 2007
Slimming at all costs: Herbalife®-induced liver injury
References
- Long-term trends in the use of complementary and alternative medical therapies in the United States. Ann Intern Med. 2001;135:262–268
- . Trends in use of complementary and alternative medicine by US adults: 1997–2002. Altern Ther Health Med. 2005;11:42–49
- . The spread of the obesity epidemic in the United States, 1991–1998. JAMA. 1999;282:1519–1522
- . Herbal hepatotoxicity. J Hepatol. 2005;43:901–910
- . Meta-analysis: antioxidant supplements for primary and secondary prevention of colorectal adenoma. Aliment Pharmacol Ther. 2006;24:281–291
- . Herbal medicines in the treatment of liver diseases. Dig Liv Dis. 2007;39:293–304
- . Physician‘s understanding of the regulation of dietary supplements. Arch Intern Med. 2007;167:966–969
- Severe hepatotoxicity associated with the dietary supplement LipoKinetix. Ann Intern Med. 2002;136:590–595
- . Two patients with acute liver injury associated with use of the herbal weight-loss supplement Hydroxycut. Ann Intern Med. 2005;142:477–478
- . Serious adverse liver reactions associated with herbal weight-loss supplements. J Hepatol. 2007;47:295–297
- Association between consumption of Herbalife® nutritional supplements and acute hepatotoxicity. J Hepatol. 2007;47:514–520
- Herbal does not mean innocuous: Ten cases of severe hepatotoxicity associated with dietary supplements from Herbalife® products. J Hepatol. 2007;47:521–526
- . Criteria of drug-induced liver disorders: report of an international consensus meeting. J Hepatol. 1990;11:272–276
- http://www.who-umc.org/DynPage,aspx?id=22682.
- . Comparison of two clinical scales for causality assessment in hepatotoxicity. Hepatology. 2001;33:123–130
- Fulminant liver failure in association with the emetic toxin of Bacillus cereus. N Engl J Med. 1997;336:1142–1148
- . Herbal remedies. N Engl J Med. 2002;347:2046–2056
- . Outcome and prognostic markers in severe drug-induced liver disease. Hepatology. 2005;42:481–489
☆ The author declared that he does not have anything to disclose regarding funding or conflict of interest with respect to this manuscript.
PII: S0168-8278(07)00406-0
doi: 10.1016/j.jhep.2007.07.010
© 2007 European Association for the Study of the Liver. Published by Elsevier Inc. All rights reserved.
« Previous
Next »
Journal of Hepatology
Volume 47, Issue 4
, Pages 444-446
, October 2007
